Catalyst Wire Dossier Catalyst Wire Dossier

Feeder DEB025

alisporivir · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Feeder DEB025, covering 2018-01-12 to 2018-01-12. Get the full timeline:

Most recent: Clinical Trial Update: 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study [Phase 3]

See pricing